A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
Condition(s):Allergic ConjunctivitisLast Updated:September 18, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Allergic ConjunctivitisLast Updated:September 18, 2012Completed
Condition(s):Allergic ConjunctivitisLast Updated:November 17, 2017Completed
Condition(s):Allergic ConjunctivitisLast Updated:October 2, 2018Withdrawn
Condition(s):Allergic ConjunctivitisLast Updated:August 18, 2014Completed
Condition(s):Allergic ConjunctivitisLast Updated:August 4, 2014Completed
Condition(s):Perennial Allergic RhinitisLast Updated:February 8, 2018Completed
Condition(s):Allergic ConjunctivitisLast Updated:April 1, 2021Recruiting
Condition(s):Eye AllergiesLast Updated:January 9, 2014Completed
Condition(s):Seasonal Allergic ConjunctivitisLast Updated:March 13, 2012Completed
Condition(s):Conjunctivitis, Allergic; Conjunctivitis, VernalLast Updated:October 22, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.